Literature DB >> 8556511

Effect of hematopoietic growth factors on human blood monocytes/macrophages in in vitro culture.

N F Hassan1, J Chehimi, W Z Ho, D E Campbell, S D Douglas.   

Abstract

The production of mature monocytes/macrophages is regulated by a group of hematopoietic growth factors, or colony-stimulating factors (CSF). We investigated the in vitro effect of human hematopoietic growth factors on human blood monocyte/macrophage differentiation and proliferation in short- and long-term in vitro cultures. The addition of macrophage CSF, granulocyte-macrophage CSF, and granulocyte CSF and interleukin-6 and interleukin-3 growth factors to monocyte/macrophage cultures induced morphological changes in cultured cells, including enhancement of cell growth and the formation of multinucleated giant cells, spindle-like cells, and fibroblast-like cells. In addition, CD4 and HLA-DR antigen expression was down regulated by the addition of growth factors without a change in the expression of other surface antigens, including CD3, CD11B, CD14, CD15, NK H1, and B1. The proliferating cell nuclear antigen was not detected in growth factor-treated nonadherent monocytes/macrophages in long-term cultures. Bromodeoxyuridine was incorporated in the adherent monocytes/macrophages, and intense staining in the small rounded cells which occur above the adherent cells in these cultures was observed after a 72-h pulse, indicating that monocytes/macrophages are slowly dividing cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556511      PMCID: PMC368375          DOI: 10.1128/cdli.1.6.620-625.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures.

Authors:  S Becker; M K Warren; S Haskill
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

2.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

Authors:  Y Koyanagi; W A O'Brien; J Q Zhao; D W Golde; J C Gasson; I S Chen
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

3.  Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons.

Authors:  M K Warren; S N Vogel
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

4.  Induction of multinucleated giant cell formation from human blood-derived monocytes by phorbol myristate acetate in in vitro culture.

Authors:  N F Hassan; N Kamani; M M Meszaros; S D Douglas
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

Review 5.  The human hematopoietic colony-stimulating factors.

Authors:  S C Clark; R Kamen
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

6.  Purification of human monocytes on gelatin-coated surfaces.

Authors:  N F Hassan; D E Campbell; S D Douglas
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

7.  Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism.

Authors:  S A Cannistra; E Vellenga; P Groshek; A Rambaldi; J D Griffin
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

8.  Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation.

Authors:  B D Chen; M Mueller; T H Chou
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

9.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.

Authors:  A McInnes; D M Rennick
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  3 in total

1.  Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors.

Authors:  M Tanaka; J Honda; Y Imamura; K Shiraishi; K Tanaka; K Oizumi
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia.

Authors:  Maria Rosa Lidonnici; Ylenia Paleari; Francesca Tiboni; Giacomo Mandelli; Claudia Rossi; Michela Vezzoli; Annamaria Aprile; Carsten Werner Lederer; Alessandro Ambrosi; Franck Chanut; Francesca Sanvito; Andrea Calabria; Valentina Poletti; Fulvio Mavilio; Eugenio Montini; Luigi Naldini; Patrizia Cristofori; Giuliana Ferrari
Journal:  Mol Ther Methods Clin Dev       Date:  2018-09-13       Impact factor: 6.698

3.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.